Watchlist Price Alert

Harvard Bioscience Inc. (HBIO)

NASDAQ: HBIO · Real-Time Price · USD

0.41

-0.06 (-12.21%)

At close: Jun 02, 2025, 3:59 PM

0.46

14.11%

After-hours: Jun 02, 2025, 07:59 PM EDT

Harvard Bioscience Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-12.4M	-3.42M	-9.52M	-288K	-7.81M	-4.69M	-3.46M	-865K	-4.31M
Depreciation & Amortization	7.16M	7M	7.58M	7.62M	7.63M	7.73M	7.88M	3.8M	4.27M
Stock-Based Compensation	4.34M	5M	4.41M	4.17M	3.65M	3.03M	3.04M	3.5M	3.5M
Other Working Capital	876K	1.71M	-917K	505K	77K	-1.64M	-3.03M	-2.54M	558K
Other Non-Cash Items	1.92M	509K	-3.62M	280K	1.9M	2.32M	-584K	16K	2.24M
Deferred Income Tax	363K	336K	-414K	-330K	-143K	-398K	-2.86M	-1.58M	-279K
Change in Working Capital	65K	4.6M	2.72M	-10.19M	4.11M	42K	-1.68M	-3.81M	-41K
Operating Cash Flow	1.44M	14.03M	1.15M	1.26M	9.33M	8.05M	2.34M	1.06M	5.38M
Capital Expenditures	-2.64M	-2.31M	-1.59M	-1.34M	-1.15M	-1.22M	-986K	-890K	-1.48M
Cash Acquisitions	n/a	512K	n/a	n/a	n/a	1M	-52.25M	12K	1.42M
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	1.92M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-619K	-523K	n/a	-150K	-250K	-15K	-16K	-27K	-1.48M
Investing Cash Flow	-1.34M	-1.8M	-1.59M	-1.34M	-1.4M	-229K	-53.26M	-917K	-62K
Debt Repayment	227K	-10.54M	-1.79M	50K	-6.89M	-7.4M	50.5M	-1.95M	-5.05M
Common Stock Repurchased	n/a	n/a	-1.63M	-3.51M	-1.14M	-221K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-358K	-2.52M	577K	-302K	70K	n/a	-2.01M	n/a	n/a
Financial Cash Flow	-131K	-12.13M	-2.84M	-252K	-7.97M	-7.63M	53.05M	-1.79M	-4.87M
Net Cash Flow	-175K	-225K	-3.31M	-496K	-18K	162K	2.44M	137K	-1.15M
Free Cash Flow	-1.2M	11.72M	-438K	-83K	8.18M	6.83M	1.36M	167K	3.9M